Product Reports Resources Pricing Login Book a demo

Yapan Bio

Biotech & Life Sciences · Hyderabad, India · Founded 2019

Your Collaborative Partner in Process Development and GMP Manufacturing for Vaccines and Biologics/Bio-therapeutics MoreLess

Yapan Bio is a specialized company operating in the biotechnology sector, focusing on the development and manufacturing of vaccines and biologics, which are medical products derived from living organisms. The company is strategically located in Genome Valley, Hyderabad, India, a premier hub for research and development (R&D) and clean manufacturing.

Yapan Bio serves a diverse range of clients, including pharmaceutical companies, biotech firms, and research institutions. These clients are typically involved in the early-stage research and development of new vaccines and biologics, and they rely on Yapan Bio for its expertise in process development and Good Manufacturing Practice (GMP) manufacturing. GMP refers to regulations that ensure products are consistently produced and controlled according to quality standards.

The company operates in the highly specialized market of biopharmaceutical manufacturing, which requires stringent quality control and regulatory compliance. Yapan Bio offers integrated services that span from early-stage research and process development to scale-up and full-scale GMP manufacturing. This means they help clients optimize their production processes to achieve high product yields, stability, and consistent manufacturing output.

Yapan Bio's business model is service-based. They generate revenue by providing specialized services in process development, optimization, and GMP manufacturing. This includes upstream and downstream development, which refers to the different stages of biopharmaceutical production. Upstream development involves the initial stages of production, such as cell culture, while downstream development involves the purification and formulation of the final product.

In summary, Yapan Bio is a key player in the biopharmaceutical manufacturing industry, offering comprehensive services that help clients bring their vaccines and biologics from the research phase to clinical trials. Their state-of-the-art facilities and expertise make them a valuable partner in this highly regulated and specialized market.

Keywords: Biopharmaceutical, GMP manufacturing, vaccines, biologics, process development, scale-up, cell culture, purification, clinical trials, Genome Valley.

Company overview

Yapan Bio company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2019
Headquarters
Hyderabad, India
Employees
54
Open positions
None listed
Dealroom signal
80.4
client focusb2bsub industryPharmaceuticalsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorVaccinessectorBiotech and PharmasectorHard Tech

Valuation & funding

Yapan Bio funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONExit Aug 2026 $7.9M $11M Piramal Pharma
EARLY VCEquity / VC Dec 2021 $14M $55M Piramal Healthcare
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 54
2025 48
2024 40
2023 31
2022 26
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Yapan Bio website traffic

Latest recorded traffic for Yapan Bio is 6K monthly website visits, up 328.6% over the last three months. Yapan Bio's team grew 12.5% over the past year.

Latest monthly visits6K 3-month web change+328.6% 1-year team growth+12.5%
Monthly website visits36 observations · Oct 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Yapan Bio compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Bonacia (Hefei) Pharmaceutical TechnologyBonacia is a CRO company specializing in clinical research , focusing on professional services for clinical research of innovative drugs, biological drugs and vaccines, and empowering the research and development of new drugs through clinical trial cloud platforms and AI China Operational 34 $14M $55M
Immorna BiotherapeuticsA biotechnology company focused on the development of mRNA-based therapeutics and vaccines Morrisville, United States Operational
Ab&B BiotechFocuses on the research and development of innovative human vaccines and multivalent vaccines Taizhou, China Operational
ZeaVaxxDeveloping a plant-derived nanoparticle that can improve animal vaccines West Lafayette, United States Operational
Normax BiomedNormax focus for 2022 is rapid growth in mRNA Vaccine R&D and manufacturing for sustainable pandemic preparedness Cork, Ireland Operational
CHA Vaccine InstituteTea vaccine research is a state-of-the-art biotech company developing vaccines and immunotherapys South Korea Operational
RVAC MedicinesMRNA platform company engaged in the research and development of innovative products such as vaccines for diseases Singapore Operational
Curevo VaccineCreating Next Generation Vaccines For Diseases Of Global Importance Seattle, United States Acquired
Showing 8 of the closest matchesCompare every metric →

Talent graph

Yapan Bio's talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on Yapan Bio's cap table

Sourced from Dealroom's funding and investor records.

Series A 1 investor entered at this stage
Piramal Healthcare
Other known 1 additional known investor
Piramal Pharma

Global footprint

Where Yapan Bio has talent and traffic

Workforce by country
1 countries with
team presence
🇮🇳 India100%
1 country shown

In the news

Latest news about Yapan Bio

Recent press, funding announcements, and product moves mentioning Yapan Bio — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Yapan Bio

An AI-synthesized read of the highest-engagement posts about Yapan Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Yapan Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.